Comparative Effectiveness of Abatacept Versus Adalimumab in Shared Epitope Positive and Negative Patients With Rheumatoid Arthritis.

Arthritis Rheumatol · 2026 · PMC12854005 · PMID 40567118

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Using a large real‐life, prospective, and UK‐wide cohort of patients with RA, we did not detect any difference in the efficacy between adalimumab and abatacept and only borderline significant associations with Val11 but not the SE.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.